The neuroendocrine effects of the 5-HT receptor agonist, sumatriptan (6 mg subcutaneously), were studied in 11 healthy male subjects using a placebo-controlled, cross-over design. Compared to placebo, sumatriptan significantly lowered levels of plasma prolactin but increased those of plasma growth hormone. There was no effect on plasma cortisol concentrations. The neuroendocrine effects of sumatriptan differ from those of previously described 5-HT-receptor agonists, and may be a consequence o...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Neuroendocrine effects of sumatriptan.
If you are the owner of this record, you can report an update to it here: Report update to this record